Aidence BV
Lung cancer screening pathway powered by Artificial Intelligence
- Funding £100,000
- Competition Cancer
- Competition Date Spring 2017
- Local AHSN Please Select
- Website http://aidence.com/
- Key Contact
- Status In Development
- Pathways Cancer
-
Technology Digital/ICT/Mobile Solutions
Aidence provides Artificial Intelligence (AI) solutions for analyses of medical images and data. Lung CAD (L-CAD) is the company’s first CE-certified software providing highly accurate detection and reporting of pulmonary nodules on CT-chest. Initially, L-CAD supports radiologists as a second reader, enabling shorter reading times and improving diagnostic accuracy.
However, we propose to develop L-CAD as first reader, reducing the radiology burden by autonomously reporting follow up studies or even acting as a filter to remove unsuspicious studies from the workflow. L-CAD is an enabler of a safe and efficient lung screening program.
Comments are closed.